Loading company…
Vedana Therapeutics develops biologic medicines for migraine prevention.
Vedana Therapeutics develops biologic medicines targeting PACAP, CGRP, and other pathways for migraine prevention. In June 2026, the company raised USD 46.00 mn in Series A funding co-led by Canaan Partners and Westlake Village BioPartners, with participation from Alexandria Venture Investments. The funding will support its antibody programs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in